Interim positron emission tomography and clinical outcome in patients with early stage Hodgkin lymphoma treated with combined modality therapy

By Filippi Andrea Riccardo  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1183-1187

Informa Healthcare

Access to resources Recommend Favorite

Residual disease after chemotherapy in aggressive malignant lymphoma: The role of radiotherapy

By Avilés Agustin   Neri Natividad   Delgado Serafin   Pérez Felipe   Nambo M.   Cleto Sergio   Talavera Alejandra   Huerta-Guzmán Judith  

Medical Oncology, Vol. 22, Iss. 4, 2005-12 ,pp. : 383-387

Humana Press, Inc

Access to resources Recommend Favorite

18Ffluorodeoxyglucose positron emission tomography/computed tomography findings of gastric lymphoma: Comparisons with gastric cancer

By            

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1757-1764

Spandidos Publications

Access to resources Recommend Favorite

Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14)

By Adde Magdalena   Enblad Gunilla   Hagberg Hans   Sundström Christer   Laurell Anna  

Medical Oncology, Vol. 23, Iss. 2, 2006-06 ,pp. : 283-293

Humana Press, Inc

Access to resources Recommend Favorite

Loss of utility of bone marrow biopsy as a staging evaluation for Hodgkin lymphoma in the positron emission tomography–computed tomography era: a West of Scotland study

By Hamilton Róisín   Andrews Iain   McKay Pamela   Leach Mike  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1049-1052

Informa Healthcare

Access to resources Recommend Favorite